About MIMS
HEADQUARTERED IN SINGAPORE
Click on locations to find out more

Singapore
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
• Reference & Clinical Decision Support

Australia
Products and Services
• Reference & Clinical Decision Support
• e-Claiming & Billing Solutions
• HCPs Recruitment Services

China
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
• HCPs Recruitment Services

Hong Kong
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications

India
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
• Reference & Clinical Decision Support

Indonesia

Ireland

Japan

Korea
Products and Services
• Marketing Platform
• Medical Communications
• Reference & Clinical Decision Support
• HCPs Recruitment Services
Malaysia
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
• HCPs Recruitment Services
Myanmar

New Zealand
Products and Services
• Reference & Clinical Decision Support
• e-Claiming & Billing Solutions
• HCPs Recruitment Services

Philippines
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications

Taiwan

Thailand
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications

UAE

Vietnam
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
OUR ECOSYSTEM

OUR TEAM
Regional Management

Sohil Goswami
Chief Executive Officer
Sohil Goswami
Chief Executive Officer
Sohil Goswami is the Chief Executive Officer of MIMS Group, leading the organisation’s mission of empowering healthcare communities to improve patient outcomes across Pacific, Southeast Asia, Middle East and beyond. He is guiding MIMS Group through its next phase of evolution—shaping a more digital, connected, and insight-driven platform for healthcare knowledge, publishing, and professional engagement.
With deep expertise in digital transformation, corporate strategy, and value-chain redesign, Sohil has spent almost 20 years working across Japan, Southeast Asia and Australia, partnering with diverse teams to modernise complex businesses. His career spans leadership roles at NEC Corporation and Deloitte Consulting in Japan, and Nomura Group in Singapore, where he drove large-scale transformation initiatives in fast-changing markets.
Since joining MIMS Group in 2019, Sohil led the transformation of the Listing Business Vertical, later expanding his scope to lead the Clinical Decision Solutions Vertical. His focus has been on re-imagining products and business models, accelerating digital innovation, and reshaping commercial and delivery capabilities to support long-term, sustainable growth.
Sohil holds an MBA in Strategy and Organisation from the National University of Singapore, is a certified Project Management Professional (PMI-PMP) and is fluent in business Japanese (JLPT N1).

Tatsuya Koike
President, Recruiting Services
Tatsuya Koike
President, Recruiting Services
Tatsuya Koike is the President of Recruiting Services in MIMS. He leads regional teams in providing recruitment services and placement of healthcare professionals in clinics and hospitals in Asia Pacific.
Tatsuya began his career at MIMS’s parent company, Senior Marketing System (SMS) Co. Ltd. in Japan in 2007 as a Sales Representative of Media Division. He quickly progressed to become the Marketing Manager of Media Planning Division in 2008 and then the Product Manager of Care Vision. He became the Business Development Manager of Overseas Division in 2013 and was the Director of SMS Asia Pte. Ltd. in Singapore for 2 years before joining MIMS Group in 2017.
Tatsuya has more than five years of experience in Business Development and Management of Medical and IT sectors. He holds a Bachelor’s Degree in Chemistry at Saitama University, Japan.

Cassie Humphreys
President, Medical Marketing
Cassie Humphreys
President, Medical Marketing
Cassie will focus on driving the strategic growth of the Medical Communications and Marketing Platform business units as 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭, 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐔𝐧𝐢𝐭.
Following a degree in Medicinal and Pharmaceutical Chemistry, Cassie embarked on a marketing career in the pharmaceutical industry. With a reputation for commercial success, Cassie held positions ranging from Brand Manager to Marketing Director within top-tier pharmaceutical companies and ground-breaking biotech organisations.
Originally from the UK, in 2011 Cassie relocated to Singapore and with it came a move into medical communications, and ultimately, MIMS Group.
Under Cassie’s leadership, the team have built a reputation for excellence – forging strategic partnerships with clients in healthcare to deliver world class services across Asia and beyond.

Yasuyuki Hayashi
Executive Vice President, MPF User Engagement Development
Yasuyuki Hayashi
Executive Vice President, MPF User Engagement Development
Yasuyuki Hayashi (Yaz) is the Executive Vice President, MPF User Engagement Development, leading the planning, development and operations of medical information and education service at MIMS.
Yaz started his career as a software engineer and R&D researcher at Rakuten, a major e-commerce company in Japan. He also spent time as a project manager at a digital marketing development firm, Information Services International-Dentsu.
In the last six years, he moved over to the business side – handling global partner alliances, post-merger integrations, business turnarounds and accelerations for
an online beauty media and fashion e-commerce business in Japan.
Yaz is now based in Singapore after joining MIMS in 2022.
He has a PhD in Applied Physics in The University of Tokyo and a Bachelor in Physics from Osaka University.

Robert Best
Executive Vice President, Clinical Decision Solutions Pacific
Robert Best
Executive Vice President, Clinical Decision Solutions Pacific
Leading the Australasian region, Robert has several roles – CEO & Executive Director for MIMS Australia and MIMS New Zealand (ANZ), CEO and Executive Director of eHealthWise Services and currently a Board Member of the MSIA (Medical Software Industry Association) in Australia.
His corporate responsibility is to drive the strategy, P&L, growth and operations across these 3 Asia-Pacific businesses, working closely with our Group CEO and Executive Team (Singapore HQ).
Robert led the acquisition of eHealthwise Services in January 2014 to SMS Co Limited, and assisted our Tokyo HQ team with the October 2015 MIMS Group acquisition.
Robert continues to focus on M&A opportunities across the region and has worked with our Shareholder owners, SMS Co, since 2013.
Robert is University Degree qualified – Bachelor of Commerce (Majors in; International Business, Technology delivery, Strategy/Marketing/Advertising/Brand Building) – he provides MIMS with 25 years of diverse skills; with significant APAC experience, Board Leadership, Corporate Governance and IP Commercialization across Public and Private Companies.
OUR HISTORY
2017
Expansion to Taiwan, China

The latest expansion meets growing demand in Taiwan for medical communications services in the healthcare industry.
The new Taiwan branch has a professional team of members from both Taiwan and Hong Kong delivering medical communications solutions catering to the Taiwan market, with a regional perspective and through a multidisciplinary and integrated approach.
2015
Launch of HCPs Recruitment Services
With the HCPs Recruitment Services, we provide career opportunities to HCPs by connecting them with healthcare institutions. Our career services professionals can tailor match the institutions’ needs to a diverse group of professionals engaged on our platform.
2013
Launch of MIMS Mobile App

To allow convenient access, MIMS developed the mobile application version of MIMS.com and released the application available for download by public on Google Playstore and Apple Store.
2008
Launch of MIMS.com
MIMS.com was enhanced and relaunched to allow registrations of HCPs onto our platform for easy access to drug information, medical news and updates.
2003-2008
Development and Launch of Clinical Decision Support Modules
Modules leveraged on the robust MIMS database and sophisticated drug interaction algorithms to enable MIMS to empower HCPs and Healthcare Institutions with accurate prescriptions, enhancing patient safety.
1981
Launch of Publications: MIMS JPOG and MIMS Doctor


1963-1980
Launch of MIMS Drug Reference Book
The 1st edition of Drug Index for Malaysia & Singapore (DIMS) was published in 1968.
MIMS Australia has been publishing medicines information since 1963. The acronym, MIMS, was derived from the original publication which was called Monthly Index of Medical Specialties.
The MIMS Drug Reference Book was subsequently published across Southeast Asia – Philippines, Hong Kong, Indonesia, Thailand, Korea, Taiwan, Vietnam, China and India.
